Compare ISO 13485:2016 to ISO 13485:2003
ISO 13485 was finally revised after 13 years and has many significant changes. The three main reasons for the updates were:
- The medical device regulatory environment has evolved since 2003;
- Risk management and risk-based decision-making processes have become the main focus of the entire medical device industry; and
- ISO 13485:2016 no longer aligns with the current version of ISO 9001, but rather aligns with the previous revision, ISO 9001:2008.
The ISO 13485:2016 standard details the changes between ISO 13485:2003 and ISO 13485:2016 in Annex A titled “Comparison of content between ISO 13485:2003 and ISO 13485:2016”. Annex B of the standard is titled “Correspondence between ISO 13485:2016 and ISO 9001:2015” which details how those two standards relate to one another. These two Annex’s are important to organizations transitioning to the new version of ISO 13485, or that are interested in being certified to both ISO 9001 and ISO 13485.
There are several key changes between the 2016 requirements and the 2003 requirements. We will discuss the 11 key changes here, which were changed to align with the FDA.
Clause 4.1 General Requirements
The first big change is the application of a risk-based approach in establishing and maintaining a QMS.
4.2 General Requirements
Within 4.2, there are two major changes. First, there is a change regarding confidential health information, and second, a large change is how to deal with deterioration and the loss of documents.
6.2 Human Resources
The newest version of the standard expands upon the 2003 version, requiring more processes to identify that individuals are competent, that they are provided with any necessary training, and make sure that personnel, and their roles are documented.
7.2 Customer-related processes
Several new terms in regards to communicating with regulatory authorities relating to product information, customer feedback, and advisory notes.
7.3 Design and Development
The 2016 version of 13485 has better aligned with the FDA.
7.3.8-Design and Development Transfer
Another big change is that this new revision has specific requirements for the transfer of products and design.
7.3.10 Design and Development Files
The old standard had no criteria regarding the requirements for maintaining documentation regarding design and development, in the new revision, these requirements are defined
There are several new requirements as it relates to purchasing. New requirements address the following:
- Monitoring and re-evaluating suppliers
- Actions to be taken when purchasing requirements are not met
- Notifying of any change in regards to purchased products
- Purchasing verification
The new standard now requires that procedures are documented as it relates to production, identification, and status.
8.2.2 Complaint handling
In the previous standard, there was no clause addressing complaints. This has changed with the new 2016 standard.
8.2.3 Reporting to regulatory authorities
There are now requirements for reporting to regulatory authorities, unlike the old version of the standard.